{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:24:11Z","timestamp":1784805851507,"version":"3.55.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:p>It has been 57 years since the first intestinal transplant. An increased incidence of graft rejection has been described compared to other solid organ transplants due to high immunogenicity of the bowel, which in health allows the balance between of dietary antigen with defense against pathogens. Expanding clinical experience, knowledge of gastrointestinal physiology and immunology have progress post-transplant immunosuppressive drug regimens. Current regimes aim to find the window between prevention of rejection and the risk of infection (the leading cause of death) and malignancy. The ultimate aim is to achieve graft tolerance. In this review we discuss advances in mucosal immunology and technologies informing the development of new anti-rejection strategies with the hope of improved survival in the next generation of transplant recipients.<\/jats:p>","DOI":"10.3389\/fnut.2022.869399","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:58:29Z","timestamp":1663941509000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Innovations in Immunosuppression for Intestinal Transplantation"],"prefix":"10.3389","volume":"9","author":[{"given":"Harween","family":"Dogra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Hind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"B1","unstructured":"POL194\/5 \u2013 Intestinal Transplantation : Patient Selection2021"},{"key":"B2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0140-6736(90)90275-A","article-title":"Successful small-bowel\/liver transplantation","volume":"335","author":"Grant","year":"1990","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1097\/00000658-199509000-00006","article-title":"Outcome analysis of 71 clinical intestinal transplantations","volume":"222","author":"Todo","year":"1995","journal-title":"Ann Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/j.1600-6143.2007.01755.x","article-title":"Analysis of acute cellular rejection episodes in recipients of primary intestinal transplantation: a single center, 11-year experience","volume":"7","author":"Selvaggi","year":"2007","journal-title":"Am J Transplant."},{"key":"B5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/SLA.0b013e318265f310","article-title":"Long-term survival, nutritional autonomy, and quality of life after intestinal and multivisceral transplantation","volume":"256","author":"Abu-Elmagd","year":"2012","journal-title":"Ann Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1600-065X.2006.00435.x","article-title":"Cellular and molecular mechanisms of liver tolerance","volume":"213","author":"Crispe","year":"2006","journal-title":"Immunol Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/ajt.12979","article-title":"Intestinal transplant registry report: global activity and trends","volume":"15","author":"Grant","year":"2015","journal-title":"Am J Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/TP.0000000000003065","article-title":"Consensus in the year 2019","volume":"104","author":"Kaufman","year":"2020","journal-title":"Transplantation."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/petr.13523","article-title":"20- to 25-year patient and graft survival following a single pediatric liver transplant\u2014analysis of the United Network of organ sharing database: where to go from here","volume":"23","author":"Ekong","year":"2019","journal-title":"Pediatr Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e13580","DOI":"10.1111\/petr.13580","article-title":"Pediatric intestinal transplantation: analysis of the intestinal transplant registry","volume":"23","author":"Raghu","year":"2019","journal-title":"Pediatr Transpl."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.716499","article-title":"Intestinal regulatory T Cells as specialized tissue-restricted immune cells in intestinal immune homeostasis and disease","volume":"12","author":"Jacobse","year":"2021","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a018341","article-title":"Regulatory T cells and immune tolerance in the intestine","volume":"5","author":"Harrison","year":"2013","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1126\/science.aaf3892","article-title":"Tissue adaptation of regulatory and intraepithelial CD4+ T cells controls gut inflammation","volume":"352","author":"Sujino","year":"2016","journal-title":"Science."},{"key":"B14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1399-3046.2008.00917.x","article-title":"Decreases in circulating CD4+CD25hiFOXP3+ cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients","volume":"13","author":"Stenard","year":"2009","journal-title":"Pediatr Transplant."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1084\/jem.20190414","article-title":"Resident memory CD8 T cells persist for years in human small intestine","volume":"216","author":"Bartolome-Casado","year":"2019","journal-title":"J Exp Med."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aav5581","article-title":"Generation and persistence of human tissue-resident memory T cells in lung transplantation","author":"Snyder","year":"2019","journal-title":"Sci Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"108661","DOI":"10.1016\/j.celrep.2020.108661","article-title":"Article human intestinal tissue-resident memory T cells comprise transcriptionally and functionally distinct subsets ll Human intestinal tissue-resident memory T cells comprise transcriptionally and functionally distinct subsets","volume":"34","author":"Fitzpatrick","year":"2021","journal-title":"Cell Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.aah3732","article-title":"Bidirectional intragraft alloreactivity drives the repopulation of human intestinal allografts and correlates with clinical outcome","volume":"1","author":"Zuber","year":"2016","journal-title":"Sci Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1111\/ajt.13325","article-title":"Macrochimerism in intestinal transplantation: association with lower rejection rates and multivisceral transplants, without GVHD","volume":"15","author":"Zuber","year":"2015","journal-title":"Am J Transplant."},{"key":"B20","year":"2020","journal-title":"Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients"},{"key":"B21","year":"2009","journal-title":"Annual report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1097\/00007890-200205270-00004","article-title":"Intestinal transplantation before and after the introduction of sirolimus","volume":"73","author":"Fishbein","year":"2002","journal-title":"Transplantation."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.transproceed.2007.02.067","article-title":"Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantationtle","volume":"39","author":"Lauro","year":"2007","journal-title":"Transpl Proc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.transproceed.2005.03.153","article-title":"Results of the Paris program: ten years of pediatric intestinal transplantation","volume":"37","author":"Goulet","year":"2005","journal-title":"Transplant Proc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/petr.13723","article-title":"Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: single-center experience","volume":"24","author":"Devine","year":"2020","journal-title":"Pediatr Transplant."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1097\/TP.0000000000003111","article-title":"Association of alemtuzumab induction with a significantly lower incidence of GVHD following intestinal transplantation: results of 445 consecutive cases from a single center","volume":"104","author":"Vianna","year":"2020","journal-title":"Transplantation."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1111\/ajt.13815","article-title":"The Leuven immunomodulatory protocol promotes T-regulatory cells and substantially prolongs survival after first intestinal transplantation","volume":"16","author":"Ceulemans","year":"2016","journal-title":"Am J Transplant"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1111\/ajt.15269","article-title":"Long-term survival in visceral transplant recipients in the new era: a single-center experience","volume":"19","author":"Elsabbagh","year":"2019","journal-title":"Am J Transplant."},{"key":"B29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1006\/jsre.1994.1121","article-title":"Intragraft expression of messenger RNA for interleukin-6 and tumor necrosis factor-\u03b1 is a predictor of rat small intestine transplant rejection","volume":"57","author":"Farmer","year":"1994","journal-title":"J Surg Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1111\/j.1600-6143.2010.03279.x","article-title":"Perioperative infliximab application ameliorates acute rejection associated inflammation after intestinal transplantation","volume":"10","author":"Pech","year":"2010","journal-title":"Am J Transplant."},{"key":"B31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/TP.0b013e31823e7abb","article-title":"Combination therapy of tacrolimus and infliximab reduces inflammatory response and dysmotility in experimental small bowel transplantation in rats","volume":"93","author":"Pech","year":"2012","journal-title":"Transplantation."},{"key":"B32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/MPG.0b013e3182293d73","article-title":"Infliximab as salvage therapy in paediatric intestinal transplant with steroid- and thymoglobulin-resistant late acute rejection","volume":"54","author":"De Greef","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/01.TP.0000072804.41125.82","article-title":"Successful infliximab treatment of steroid and OKT3 refractory acute cellular rejection in two patients after intestinal transplantation","volume":"76","author":"Pascher","year":"2003","journal-title":"Transplantation."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1016\/j.transproceed.2004.09.023","article-title":"Anti-TNF-alpha therapy for acute rejection in intestinal transplantation","volume":"37","author":"Pascher","year":"2005","journal-title":"Transplant Proc."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1600-6143.2011.03497.x","article-title":"Tumor necrosis factor alpha inhibitors as immunomodulatory antirejection agents after intestinal transplantation","volume":"11","author":"Gerlach","year":"2011","journal-title":"Am J Transplant."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/ajt.16283","article-title":"Rejection of intestinal allotransplants is driven by memory T helper type 17 immunity and responds to infliximab","volume":"21","author":"Kroemer","year":"2021","journal-title":"Am J Transplant."},{"key":"B37","doi-asserted-by":"publisher","first-page":"101246","DOI":"10.1016\/j.trim.2019.101246","article-title":"The effect of a novel immunosuppressive drug, a PAK-2 inhibitor, on macrophage differentiation\/polarization in a rat small intestinal transplantation model","volume":"57","author":"Kodama","year":"2019","journal-title":"Transpl Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/TXD.0000000000000973","article-title":"Safe and successful treatment of acute cellular rejection of an intestine and abdominal wall transplant with vedolizumab","volume":"17","author":"Trentadue","year":"2020","journal-title":"Transplant Direct"},{"key":"B39","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1399-3046.2011.01543.x","article-title":"Proteasome inhibitor therapy for antibody-mediated rejection","volume":"15","author":"Woodle","year":"2011","journal-title":"Pediatr Transplant."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1097\/TP.0b013e3181fdd9b0","article-title":"The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation","volume":"90","author":"Flechner","year":"2010","journal-title":"Transplantation."},{"key":"B41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.transproceed.2015.09.073","article-title":"Effectiveness of bortezomib in a patient with acute rejection associated with an elevation of donor-specific HLA antibodies after small-bowel transplantation: case report","volume":"48","author":"Fujiwara","year":"2016","journal-title":"Transplant Proc"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/tri.13672","article-title":"Donor's graft ex vivo T-cell depletion with fludarabine reduces graft-vs.-host disease signs and improves survival after intestinal transplantation \u2013 an experimental study","volume":"33","author":"Vela","year":"2020","journal-title":"Transpl Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/jpen.1423","article-title":"The gut microbiome in patients with intestinal failure: current evidence and implications for clinical practice","volume":"43","author":"Neelis","year":"2019","journal-title":"J Parenter Enter Nutr."},{"key":"B44","doi-asserted-by":"publisher","first-page":"17187","DOI":"10.1073\/pnas.0904847106","article-title":"Human gut microbiome adopts an alternative state following small bowel transplantation","volume":"106","author":"Hartman","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2011.03860.x","article-title":"Characterization of the ileal microbiota in rejecting and non-rejecting recipients of small bowel transplants","volume":"12","author":"Oh","year":"2012","journal-title":"Am J Transplant."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1182\/blood-2015-04-638858","article-title":"Low urinary indoxyl sulfate levels early after transplantation reflect a disrupted microbiome and are associated with poor outcome","volume":"126","author":"Weber","year":"2015","journal-title":"Blood."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1097\/TP.0b013e3181fdda0d","article-title":"Toll-like receptor 4 contributes to small intestine allograft rejection","volume":"90","author":"Krams","year":"2010","journal-title":"Transplantation."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e20460","DOI":"10.1371\/journal.pone.0020460","article-title":"Fish oil enhances recovery of intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplant","volume":"6","author":"Li","year":"2011","journal-title":"PLoS ONE"},{"key":"B49","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/ajt.12577","article-title":"Fecal microbiota transplantation for refractory Clostridium difficile colitis in solid organ transplant recipients","volume":"14","author":"Friedman-Moraco","year":"2014","journal-title":"Am J Transplant."},{"key":"B50","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ajt.15058","article-title":"Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: a multicenter experience","volume":"19","author":"Cheng","year":"2019","journal-title":"Am J Transplant."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1111\/ajt.15700","article-title":"Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation","volume":"20","author":"S\u00e1nchez-Fueyo","year":"2020","journal-title":"Am J Transplant."},{"key":"B52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature09691","article-title":"Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro","volume":"470","author":"Spence","year":"2011","journal-title":"Nature."},{"key":"B53","doi-asserted-by":"publisher","first-page":"G664","DOI":"10.1152\/ajpgi.00111.2014","article-title":"Human and mouse tissue-engineered small intestine both demonstrate digestive and absorptive function","volume":"308","author":"Grant","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nm.4233","article-title":"Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system","volume":"23","author":"Workman","year":"2017","journal-title":"Nat Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/01.sla.0000143246.07277.73","article-title":"Tissue-engineered small intestine improves recovery after massive small bowel resection","volume":"240","author":"Grikscheit","year":"2004","journal-title":"Ann Surg."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1038\/s41591-020-1024-z","article-title":"Engineering transplantable jejunal mucosal grafts using patient-derived organoids from children with intestinal failure","volume":"26","author":"Meran","year":"2020","journal-title":"Nat Med"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.869399\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T13:58:32Z","timestamp":1663941512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2022.869399\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":56,"alternative-id":["10.3389\/fnut.2022.869399"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2022.869399","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"article-number":"869399"}}